Ropes Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $737K | Sell |
8,100
-148
| -2% | -$13K | 0.14% | 125 |
|
|
2023
Q2 | $667K | Sell |
8,248
-50
| -0.6% | -$4.08K | 0.11% | 149 |
|
|
2023
Q1 | $660K | Sell |
8,298
-600
| -7% | -$42.5K | 0.12% | 150 |
|
|
2022
Q4 | $602K | Sell |
8,898
-5,500
| -38% | -$322K | 0.11% | 151 |
|
|
2022
Q3 | $717K | Hold |
14,398
| – | – | 0.15% | 127 |
|
|
2022
Q2 | $802K | Buy |
14,398
+18
| +0.1% | +$999 | 0.16% | 123 |
|
|
2022
Q1 | $798K | Buy |
14,380
+80
| +0.6% | +$4.11K | 0.14% | 140 |
|
|
2021
Q4 | $801K | Sell |
14,300
-550
| -4% | -$29.8K | 0.14% | 124 |
|
|
2021
Q3 | $713K | Sell |
14,850
-30
| -0.2% | -$1.45K | 0.11% | 148 |
|
|
2021
Q2 | $623K | Hold |
14,880
| – | – | 0.1% | 157 |
|
|
2021
Q1 | $570K | Hold |
14,880
| – | – | 0.1% | 157 |
|
|
2020
Q4 | $520K | Sell |
14,880
-20
| -0.1% | -$691 | 0.08% | 151 |
|
|
2020
Q3 | $517K | Sell |
14,900
-1,000
| -6% | -$33.3K | 0.1% | 142 |
|
|
2020
Q2 | $521K | Buy |
15,900
+700
| +5% | +$22.3K | 0.11% | 131 |
|
|
2020
Q1 | $458K | Hold |
15,200
| – | – | 0.12% | 124 |
|
|
2019
Q4 | $440K | Sell |
15,200
-10,000
| -40% | -$277K | 0.09% | 153 |
|
|
2019
Q3 | $651K | Buy |
25,200
+5,468
| +28% | +$138K | 0.14% | 118 |
|
|
2019
Q2 | $504K | Buy |
19,732
+200
| +1% | +$4.94K | 0.11% | 140 |
|
|
2019
Q1 | $511K | Hold |
19,532
| – | – | 0.14% | 134 |
|
|
2018
Q4 | $450K | Sell |
19,532
-150
| -0.8% | -$3.33K | 0.13% | 139 |
|
|
2018
Q3 | $464K | Buy |
19,682
+16,000
| +435% | +$390K | 0.11% | 150 |
|
|
2018
Q2 | $85K | Hold |
3,682
| – | – | 0.02% | 300 |
|
|
2018
Q1 | $91K | Buy |
3,682
+1,000
| +37% | +$26.3K | 0.02% | 276 |
|
|
2017
Q4 | $72K | Buy |
2,682
+400
| +18% | +$10.2K | 0.02% | 309 |
|
|
2017
Q3 | $55K | Hold |
2,282
| – | – | 0.01% | 321 |
|
|
2017
Q2 | $49K | Hold |
2,282
| – | – | 0.01% | 337 |
|
|
2017
Q1 | $39K | Hold |
2,282
| – | – | 0.01% | 353 |
|
|
2016
Q4 | $41K | Hold |
2,282
| – | – | 0.01% | 338 |
|
|
2016
Q3 | $47K | Buy |
2,282
+532
| +30% | +$13.2K | 0.02% | 282 |
|
|
2016
Q2 | $47K | Hold |
1,750
| – | – | 0.02% | 263 |
|
|
2016
Q1 | $47K | Buy |
1,750
+1,000
| +133% | +$26.8K | 0.02% | 221 |
|
|
2015
Q4 | $22K | Hold |
750
| – | – | 0.01% | 300 |
|
|
2015
Q3 | $20K | Sell |
750
-2,000
| -73% | -$56.6K | 0.01% | 314 |
|
|
2015
Q2 | $75K | Sell |
2,750
-750
| -21% | -$21.1K | 0.04% | 169 |
|
|
2015
Q1 | $93K | Buy |
+3,500
| New | +$80.6K | 0.05% | 162 |
|
Other funds holding NVO
F
Ropes Wealth Advisors's NVO Position: Q3 2023 in Review
Ropes Wealth Advisors reduced its Novo Nordisk (NVO) stake by 1.8% in Q3 2023, selling an estimated $13K and leaving 8,100 shares worth $737K. The position accounts for 0.14% of the portfolio, ranked #125.
Ropes Wealth Advisors first reported a position in NVO in Q1 2015 and has held it in 35 quarters since. The position peaked at $802K in Q2 2022. 1,306 funds tracked by Wall St. Rank hold NVO as of Q3 2023.
- Ropes Wealth Advisors held 8,100 shares of Novo Nordisk worth $737K as of Q3 2023.
- Ropes Wealth Advisors sold 148 Novo Nordisk shares in Q3 2023, an estimated $13K.
- Novo Nordisk made up 0.14% of Ropes Wealth Advisors's portfolio in Q3 2023, its #125 holding.
- Ropes Wealth Advisors first reported a position in Novo Nordisk in Q1 2015 and has held it in 35 quarters since.
- Ropes Wealth Advisors's Novo Nordisk position peaked at $802K in Q2 2022.
- 1,306 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.
Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.